A review of the mechanism of action and clinical applications of sorafenib in advanced osteosarcoma
Objective: To summarise the contemporary literature regarding sorafenib and its effectiveness as a novel treatment in advanced osteosarcoma. Background: Modern treatment has seen the cure rate of osteosarcoma increase to 65%. However, in patients who do not achieve remission, prognosis is poor, as t...
Main Author: | James Coventon |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Journal of Bone Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137417300520 |
Similar Items
-
CLINICAL EXPERIENCE OF NEXAVAR (SORAFENIB) APPLICATION IN PATIENTS WITH METASTATIC DIFFERENTIATED THYROID CANCER RESISTANT TO THERAPY 131I
by: P. A. Isaev, et al.
Published: (2015-04-01) -
Metastatic renal cell carcinoma: A guide to therapy based on current evidence
by: Choueiri Toni
Published: (2009-01-01) -
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
by: Yi-Ling Ko, et al.
Published: (2020-04-01) -
Inhibition of retinopathy of prematurity in rat by intravitreal injection of sorafenib
by: Li-Li Tian, et al.
Published: (2014-04-01) -
Sorafenib-induced pemphigus vulgaris
by: Ajay Deshpande
Published: (2016-01-01)